Clotilde Théry
Clotilde Théry is a professor and INSERM director of research (DR2) at Institut Curie in Paris, France.[1][2] She is president of the International Society for Extracellular Vesicles (ISEV), where she previously served as founding secretary general and as editor-in-chief of the Journal of Extracellular Vesicles. She is the team leader of the group "Extracellular Vesicles, Immune Responses and Cancer" within the INSERM Unit 932 focusing on "Immunity and Cancer." Théry researches extracellular vesicles that are released by immune and tumor cells, including exosomes that originate in the multivesicular body. CareerAfter earning a PhD in France, Théry completed her first post-doctoral fellowship in the United Kingdom and the United States, focusing on the developmental biology of the nervous system. Upon returning to France, Théry took up the topic of cell biology of immune responses at Institut Curie. Théry began studying exosomes in 1998, at a time when extracellular vesicles (EVs) were largely regarded as inimportant or even artifacts.[3] In 2007, Théry's current team on Extracellular Vesicles, Immune responses and Cancer was started at Institut Curie, which is now a member of the PSL Research University. ResearchThéry's lab focuses on understanding how EVs, including exosomes, facilitate communication between cells of the immune system and cancer cells. She is the most cited author of several cell biology journals, including Annual Review of Cell and Developmental Biology, Current protocols in cell biology, and the Journal of Extracellular Vesicles.[4] Leadership and awards
References
|